Alkermes
Logotype for Alkermes plc

Alkermes (ALKS) investor relations material

Alkermes TD Cowen 46th Annual Health Care Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Alkermes plc
TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026

Business transformation and strategic positioning

  • Completed a significant transition in 2025, consolidating focus around sleep medicine and expanding with the acquisition of Avadel.

  • Now positioned as a major player in the sleep medicine market, leveraging a strong, cash-generative base business to fund pipeline growth.

  • Acquisition of Avadel adds oxybate to the portfolio, supporting both current market presence and the upcoming launch of alixorexton.

  • Integration of Avadel's experienced commercial team is expected to enhance future product launches.

  • Commercial infrastructure is now scalable and profitable, supporting aggressive pipeline investment.

Sleep medicine and narcolepsy market insights

  • Oxybates remain a key treatment for narcolepsy, especially as diagnosis and treatment rates increase.

  • The company is uniquely positioned to research and develop combined daytime and nighttime therapies for narcolepsy.

  • There is a large gap between narcolepsy prevalence and treatment, with significant unmet patient needs.

  • The launch of alixorexton is expected to benefit from established commercial relationships in specialized sleep centers.

Orexin agonist development and clinical program

  • Phase II data for orexin 2 receptor agonists show strong safety, tolerability, and efficacy, with once-daily and split dosing options.

  • Phase III program includes three studies (two NT1, one NT2), with endpoints such as Maintenance of Wakefulness Test (MWT) and Epworth Sleepiness Scale (ESS).

  • Split dosing is being incorporated to extend wakefulness for patients who need it.

  • Methodological improvements in cataplexy monitoring and site quality are being applied in phase III.

  • Data for idiopathic hypersomnia (IH) are expected soon, with both LUMRYZ and orexin compounds being evaluated.

How does Avadel acquisition enhance alixorexton launch?
How does Alkermes define normalcy in narcolepsy?
Strategic rationale for orexin expansion beyond narcolepsy?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Alkermes earnings date

Logotype for Alkermes plc
Q1 202630 Apr, 2026
Alkermes
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Alkermes earnings date

Logotype for Alkermes plc
Q1 202630 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Alkermes plc is a biopharmaceutical company engaged in the development, manufacturing, and commercialization of innovative medicines. The company focuses on therapies for central nervous system disorders, including schizophrenia, bipolar disorder, and addiction, as well as treatments for other chronic diseases. Alkermes serves the healthcare sector by advancing solutions that address unmet medical needs. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage